Cookie policy: This site uses cookies (small files stored on your computer) to simplify and improve your experience of this website. Cookies are small text files stored on the device you are using to access this website. For more information please take a look at our terms and conditions. Some parts of the site may not work properly if you choose not to accept cookies.


Subscribe or Register

Existing user? Login


Ixekizumab clears psoriasis in up to 80% of patients

After 12 weeks of treatment with ixekizumab, more than three-quarters of patients had clear or minimal psoriasis.

Back of a female suffering from sever psoriasis

Source: Bobjgalindo / Wikimedia Commons

Psoriasis is characterised by itchy red patches on the skin as a result of a flaw in the immune system and inflammation 

Psoriasis is a chronic inflammatory disease caused by dysregulated immune responses. Recent advances in understanding the underlying cytokine networks has led to attempts to create drugs that can completely clear psoriasis plaques. 

In three phase III trials, researchers explored the efficacy of ixekizumab, a monoclonal antibody against interleukin-17a, in a total of 3,866 patients with moderate to severe psoriasis. 

They found that, after 12 weeks, 76.4–81.8% of patients who were randomly assigned to active treatment had minimal or clear psoriasis, compared with 3.2% of patients assigned to placebo. At week 60, 68.7–78.3% of patients who received ixekizumab had maintained their improvement. 

In The New England Journal of Medicine (online, 8 June 2016)[1], the researchers say the response rates are some of the highest ever seen from a psoriasis drug, but caution that long-term safety needs assessment.

Citation: Clinical Pharmacist DOI: 10.1211/CP.2016.20201293

Have your say

For commenting, please login or register as a user and agree to our Community Guidelines. You will be re-directed back to this page where you will have the ability to comment.

Recommended from Pharmaceutical Press

Search an extensive range of the world’s most trusted resources

Powered by MedicinesComplete
  • Print
  • Share
  • Comment
  • Save
  • Print Friendly Version of this pagePrint Get a PDF version of this webpagePDF

Supplementary images

  • Back of a female suffering from severe psoriasis

Newsletter Sign-up

Want to keep up with the latest news, comment and CPD articles in pharmacy and science? Subscribe to our free alerts.